Clinical trial
Pulmonary Hypertension in Patients With Sickle Cell Disease in Nigeria
NCT00367523 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00367523 |
|---|---|
| Title | Pulmonary Hypertension in Patients With Sickle Cell Disease in Nigeria |
| Official title | Prevalence of Secondary Arterial Hypertension (PAH) in Patients With Sickle Cell Disease in Nigeria and the Role of HIV/AIDS and Endemic Parasitic Infections in the Natural History of Pulmonary Hypertension in Sickle Cell Disease |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Secondary Pulmonary Arterial Hypertension, Sickle Cell Disease, Pulmonary Hypertension |
| Enrollment | 308 |
| Start date | Jun 15, 2006 |
| Completion | Sep 28, 2017 |
| First posted | Aug 23, 2006 |
| Last update posted | Nov 29, 2019 |
| Countries | Nigeria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: